Highlights Sanofi Xetra

Equities

SNW

FR0000120578

Market Closed - Xetra Other stock markets 11:35:46 2024-05-31 EDT			5-day change	1st Jan Change
89.78 ^EUR	+1.23%		+0.54%	+0.04%

05-31	CAC40: at the 8000 pts threshold, loses nearly 1.3% over the week	CF
05-31	CAC40: remains at equilibrium despite sharp decline in Nasdaq and S&P	CF

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

CAC40: remains at equilibrium despite sharp decline in Nasdaq and S&P	05-31	CF
CAC40: May ends with no trend and a zero score	05-31	CF
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review	05-31	RE
Sanofi: launch of employee share ownership plan 2024	05-31	CF
Regeneron Pharmaceuticals, Sanofi Say Dupixent FDA Application Decision Delayed by 3 Months	05-31	MT
Regeneron Pharmaceuticals, Inc and Sanofi Announces Update on FDA Priority Review of Dupixent® for the Treatment of COPD Patients with Type 2 Inflammation	05-31	CI
CAC40: regains some altitude, Airbus in support	05-30	CF
Sanofi Closes Purchase of US Biotech Company Inhibrx	05-30	MT
Sanofi: acquisition of Inhibrx finalized	05-30	CF
Sanofi Opens New Advanced Vaccines Facility, Strengthening Its Commitment to Biomanufacturing in Canada	05-30	CI
EU okays $1.5 bln state funded joint hydrogen project, $1.1 bln joint healthcare project	05-28	RE
Sanofi Gets US FDA’s Priority Review for Expanded Use of Blood Cancer Drug Sarclisa	05-27	MT
Sarclisa Accepts for FDA Priority Review for the Treatment of Transplant-Ineligible Newly Diagnosed Multiple Myeloma	05-27	CI
Inhibrx Shareholders Approve Sale of INBRX-101 Assets to Sanofi	05-24	MT
Novavax awaits FDA decision on whether its next COVID shot can be offered in US	05-24	RE
Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	05-23	MT
Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million	05-22	RE
Sanofi Partners with Microsoft-Backed OpenAI, Formation Bio to Develop Drugs with AI	05-21	MT
Sanofi Teams Up with Formation Bio, OpenAI for Drug Development AI Software	05-21	MT
Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration	05-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SANOFI : Sanofi’s healthy Q1 performance hailed by markets

April 25, 2024 at 07:58 am

Sanofi Sees Trend for Years of Steady Growth: CFO

February 03, 2023 at 03:56 pm